<DOC>
<DOCNO>EP-0639567</DOCNO> 
<TEXT>
<INVENTION-TITLE>
INDOLE DERIVATIVE.
</INVENTION-TITLE>
<CLASSIFICATIONS>C07D20900	C07D20910	C07D40100	C07D40112	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07D	C07D	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07D209	C07D209	C07D401	C07D401	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
An indole derivative represented by general formula (1). It has a potent antiestrogenic effect and hence is 
useful for treating 

estrogen-dependent diseases such as anovular infertility, prostatomegaly, osteoporosis, breast cancer, endometrial 
cancer and melanoma. 


</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
OTSUKA PHARMA CO LTD
</APPLICANT-NAME>
<APPLICANT-NAME>
OTSUKA PHARMACEUTICAL FACTORY, INC.
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
INAI MASATOSHI - AZA KITAWAKE
</INVENTOR-NAME>
<INVENTOR-NAME>
KANAYA JUN - AZA HIGASHIBIRAKI
</INVENTOR-NAME>
<INVENTOR-NAME>
MORITAKE MASAKO - NAKASHOWA-CH
</INVENTOR-NAME>
<INVENTOR-NAME>
SHIBUTANI TADANAO - AZA MITSUH
</INVENTOR-NAME>
<INVENTOR-NAME>
TANAKA AKIE AZA HON-CHO BEZAIT
</INVENTOR-NAME>
<INVENTOR-NAME>
INAI, MASATOSHI 20-1, AZA KITAWAKE YAGAMI
</INVENTOR-NAME>
<INVENTOR-NAME>
KANAYA, JUN 22-7, AZA HIGASHIBIRAKI NAKAMURA
</INVENTOR-NAME>
<INVENTOR-NAME>
MORITAKE, MASAKO 38-1, NAKASHOWA-CHO 1-CHOME
</INVENTOR-NAME>
<INVENTOR-NAME>
SHIBUTANI, TADANAO 96-1, AZA MITSUHOKAITAKU
</INVENTOR-NAME>
<INVENTOR-NAME>
TANAKA, AKIE 32, AZA HON-CHO BEZAITEN MUYA-CHO
</INVENTOR-NAME>
</INVENTORS>
<DESCRIPTION>
The present invention relates to novel indole 
derivatives. The indole derivatives of the invention are 
novel compounds not yet described in the literature. It is an object of the invention to provide 
compounds useful as drugs, as mentioned later herein. According to the invention, indole derivatives 
of the general formula (1) shown below are provided. 
   In the above formula, R¹ is a halogen atom, R² 
is a hydrogen atom, a lower alkyl group, a lower alkanoyl 
group or a benzoyl group, R³ is a hydrogen atom, a lower 
alkyl group or a halogen atom, R⁴ is a thienyl group or a 
group of the formula 
(in which R⁶ is a lower alkyl group, a cycloalkyl group, 
a phenyl group which may optionally have a lower alkyl 
group as a substituent, a phenyl-lower alkyl group or a 
pyridyl group, R⁷ is a hydrogen atom or a lower alkyl  
 
group, Q is a sulfur or selenium atom and n is an integer 
of 0 to 2), A is an alkylene group, m is an integer of 0 
to 1, R⁵ is a hydrogen atom, an alkyl group or a benzoyl 
group having a hydroxyl group or a group of the formula 
-O-B-R⁸ (in which B is a lower alkylene group and R⁸ is a 
phenyl, di-lower alkyl-amino, 1-pyrrolidinyl, piperidino, 
1-imidazolyl or 1,2,4-triazol-1-yl group) as a 
substituent when m is 0 or, when m is 1, R⁵ is a lower 
alkoxycarbonyl group, a carboxyl group, a hydroxyl group, 
a group of the formula -C(=O)-N(R⁹)-R¹⁰ (in which R⁹ and 
R¹⁰ are the same or different and each is a hydrogen 
atom, a lower alkyl group, a cycloalkyl group which may 
optionally have a benzene ring condensed thereto, a 
phenyl group, a phenyl-lower alkyl group or a lower 
alkylsulfonyl group or R⁹ and R¹⁰ are bound to each other 
either directly or via an oxygen or sulfur atom to form, 
together with the adjacent nitrogen atom, a heterocyclic 
group which may optionally be substituted with a lower 
alkoxycarbonyl or carboxyl group), a group of the formula 
-CH₂-N(R¹¹)-R¹² (in which R¹¹ and R¹² are the same or 
different and each is a hydrogen atom, a lower alkyl 
group, a cycloalkyl group which may optionally have a 
benzene ring condensed thereto, a phenyl group, a phenyl-lower 
alkyl group or a lower alkanoyl group or R¹¹ and 
R¹² are bound to each other either directly or via an  
 
oxygen or sulfur atom to form, together with the adjacent 
nitrogen atom, a heterocyclic group which may optionally 
be substituted with a lower alkoxycarbonyl or carboxyl 
group), a group of the formula -OR¹³ (in which R¹³ is a 
lower alkylcarbamoylphenyl group, a lower alkylaminomethylphenyl 
gr
</DESCRIPTION>
<CLAIMS>
An indole derivative of the general formula 
 

wherein R¹ is a halogen atom, R² is a hydrogen atom, a 
lower alkyl group, a lower alkanoyl group or a benzoyl 

group, R³ is a hydrogen atom, a lower alkyl group or a 
halogen atom, R⁴ is a thienyl group or a group of the 

formula 
 

(in which R⁶ is a lower alkyl group, a cycloalkyl group, 
a phenyl group which may optionally have a lower alkyl 

group as a substituent, a phenyl-lower alkyl group or a 

pyridyl group, R⁷ is a hydrogen atom or a lower alkyl 
group, Q is a sulfur or selenium atom and n is an integer 

of 0 to 2), A is an alkylene group, m is an integer of 0 
to 1, R⁵ is a hydrogen atom, an alkyl group or a benzoyl 

group having a hydroxyl group or a group of the formula 
-O-B-R⁸ (in which B is a lower alkylene group and R⁸ is a 

phenyl, di-lower alkyl-amino, 1-pyrrolidinyl, piperidino, 
1-imidazolyl or 1,2,4-triazol-1-yl group) as a 

substituent when m is 0 or, when m is 1, R⁵ is a lower 
 

alkoxycarbonyl group, a carboxyl group, a hydroxyl group, 
a group of the formula -C(=O)-N(R⁹)-R¹⁰ (in which R⁹ and 

R¹⁰ are the same or different and each is a hydrogen 
atom, a lower alkyl group, a cycloalkyl group which may 

optionally have a benzene ring fused or condensed 
thereto, a phenyl group, a phenyl-lower alkyl group or a 

lower alkylsulfonyl group or R⁹ and R¹⁰ are bound to each 
other either directly or via an oxygen or sulfur atom to 

form, together with the adjacent nitrogen atom, a 
heterocyclic group which may optionally be substituted 

with a lower alkoxycarbonyl or carboxyl group), a group 
of the formula -CH₂-N(R¹¹)-R¹² (in which R¹¹ and R¹² are 

the same or different and each is a hydrogen atom, a 
lower alkyl group, a cycloalkyl group which may 

optionally have a benzene ring condensed thereto, a 
phenyl group, a phenyl-lower alkyl group or a lower 

alkanoyl group or R¹¹ and R¹² are bound to each other 
either directly or via an oxygen or sulfur atom to form, 

together with the adjacent nitrogen atom, a heterocyclic 
group which may optionally be substituted with a lower 

alkoxycarbonyl or carboxyl group), a group of the formula 
-OR¹³ (in which R¹³ is a lower alkylcarbamoylphenyl 

group, a lower alkylaminomethylphenyl group, a lower 
alkylaminomethylpehnyl group, a 1-pyrrolidinylcarbonylphenyl 

group, a 1-pyrrolidinylmethylphenyl group, a 2-di-lower 
 

alkylaminoethyl group or a 2-hydroxyl-2-lower 
alkylaminoethyl group) or a phenyl group which may 

optionally have a hydroxyl, lower alkoxy, 1-pyrrolidinylcarbonyl 
or 1-pyrrolidinylmethyl group as a substituent, 

and x is an integer of 0 to 2. 
An indole derivative as claimed in Claim 1, 
wherein R² is a hydrogen atom, R³ is a hydrogen atom or a 

lower alkyl group, R⁴ is a group of the formula 
 

(in which R⁶ is a lower alkyl group, a cycloalkyl group, 
a phenyl group which may optionally have one or more 

lower alkyl groups as substituents, a phenyl-lower alkyl 
group or a pyridyl group) and m is 1. 
An indole derivative as claimed in Claim 2, 
wherein R⁵ is a group of the formula -C(=O)-N(R⁹)-R¹⁰ (in 

which R⁹ and R¹⁰ are the same or different and each is a 
hydrogen atom, a lower alkyl group, a cycloalkyl group 

which may optionally have a benzene ring condensed 
thereto, a phenyl group, a phenyl-lower alkyl group or a 

lower alkylsulfonyl group or R⁹ and R¹⁰ are bound to each 
other either directly or via an oxygen or sulfur atom to 

form, together with the adjacent nitrogen atom, a 
heterocyclic group which may optionally be substituted 

with a lower alkoxycarbonyl or carboxyl group) or a group 
 

of the formula -CH₂-N(R¹¹)-R¹² (in which R¹¹ and R¹² are 
the same or different and each is a hydrogen atom, a 

lower alkyl group, a cycloalkyl group which may 
optionally have a benzene ring condensed thereto, a 

phenyl group, a phenyl-lower alkyl group or a lower 
alkanoyl group or R¹¹ and R¹² are bound to each other 

either directly or via an oxygen or sulfur atom to form, 
together with the adjacent nitrogen atom, a heterocyclic 

group which may optionally be substituted with a lower 
alkoxycarbonyl or carboxyl group). 
An indole derivative as claimed in Claim 1, 
said derivative being of the formula 

 
wherein R³ is a hydrogen atom, a lower alkyl group or a 

halogen atom, R⁶ is a lower alkyl group, a cycloalkyl 
group, a phenyl group which may optionally have one or 

more lower alkyl groups as substituents, a phenyl-lower 
alkyl group or a pyridyl group, and R¹¹ and R¹² are the 

same or different and each is a hydrogen atom, a lower 
alkyl group, a cycloalkyl group which may optionally have 

a benzene ring condensed thereto, a phenyl group, a 
 

phenyl-lower alkyl group or a lower alkanoyl group or R¹¹ 
and R¹² are bound to each other either directly or via an 

oxygen or sulfur atom to form, together with the adjacent 
nitrogen atom, a heterocyclic group which may optionally 

be substituted with a lower alkoxycarbonyl or carboxyl 
group. 
An estrogen inhibitor which comprises the 
indole derivative of Claim 1 as an active ingredient. 
An estrogen inhibitor which comprises the 
indole derivative of Claim 3 as an active ingredient. 
An estrogen inhibitor which comprises the 
indole derivative of Claim 4 as an active ingredient. 
A method of treating an estrogen-dependent 
disease which comprises administering a pharmacologically 

effective amount of the estrogen inhibitor of Claim 5 to 
the patient. 
</CLAIMS>
</TEXT>
</DOC>
